One leading example of a broadly effective metabolic disease therapeutic is semaglutide, a long-acting glucagon-like peptide 1 (GLP-1) analogue that is approved for clinical use [3] and has been shown to both improve weight loss and decrease blood glucose [4]. This evidence concerns the gene GCG and metabolic disease.